Bolder Capital has completed its acquisition of Monti Eligibility and Denial Solutions Inc. and the Monti Group Inc., collectively called MEDS. MEDS is a provider of patient eligibility, enrollment and revenue recovery services to hospitals and health systems. Terms were not released.
Bolder Capital announced today that it has recently completed the acquisition of Monti Eligibility and Denial Solutions, Inc. and the Monti Group, Inc., collectively called MEDS (“MEDS” or the “Company”). MEDS is an outsourced provider of patient eligibility, enrollment and revenue recovery services to hospitals and health systems. MEDS customers are located in Florida, Indiana and Ohio.
MEDS is the first acquisition completed by Bolder Healthcare Solutions LLC (“BHS”). BHS is led by Michael Shea who has partnered with Bolder Capital to build a leading specialized provider of revenue cycle management services. Mr. Shea was previously the founder and CEO of MedAssist, an innovator and leader in patient eligibility and other revenue cycle services. Mr. Shea led the sale of MedAssist to Firstsource Solutions where he continued to lead MedAssist and to serve as President of Global Healthcare Solutions for Firstsource until 2010.
Mr. Shea commented “We are very pleased to be acquiring and investing in a high quality company like MEDS. The MEDS management team is working closely with me as we continue to deliver outstanding customer service while increasing our capabilities and reach. Bolder Healthcare Solutions is committed to bringing together best of breed companies, people, products and technologies across the health care revenue cycle”.
Bolder Capital has been formed through a co-investment relationship with The Edgewater Funds and JZ Capital Partners. Bolder brings access to over $2 billion in assets under management and experience from hundreds of private equity transactions dating back over 35 years. Bolder Capital has partnered with Michael Shea to form Bolder Healthcare Solutions to acquire and grow best of class companies across the healthcare revenue cycle. BHS will also expand organically though the acquisition of new clients, addition of highly talented management and strategic partnerships within the industry.